We back early-stage businesses whose technologies have the potential to solve our planet's biggest challenges and
achieve significant commercial growth. We target long-term value creation, while working with founders and
entrepreneurs to accelerate the development and implementation of positive impact technologies.
Core
Our Core investment vertical focuses on our three complementary investment sectors of decarbonisation,
sustainable energy and social impact. Typically receiving seed or pre-seed funding, our core investees benefit
from EBC’s hands-on approach to accelerating growth.
World's first raspberry picking robot
Fieldwork Robotics has developed the first autonomous raspberry harvesting robot, in collaboration with Bosch. The robot, named Alpha, analyses the crop, decides when to harvest the raspberries, and places them in punnets ready for delivery to supermarkets.
Allye provides distributed energy storage at the grid edge to lower consumer costs, promote local grid resiliency and accelerate decarbonisation. Allye’s first product, the Max is the world’s first mobile energy storage system that repurposes healthy battery packs from EVs.
Omnevue has developed cutting-edge software to deliver audit-grade ESG accounting, think Quickbooks for ESG. The platform collects a company's financial data, HR data and other data sources, analysing them and producing a report that is comparable with international accounting standards.
upp combines AI-harvest automation technology and side stream upcycling to deliver clean, sustainable and nutritious broccoli protein. The UK is one of the largest broccoli producers in the world but is reliant on scarce and expensive labour to harvest broccoli heads by hand, enter upp.
Unwasted’s Neverwaste™ is the world’s first high performance, mass production panel board made entirely from waste cardboard and packaging. By refining and modifying the fibres of cardboard, Neverwaste™ avoids the use of glues, resins and toxic chemicals in the production of a premium-spec
Munro was established in 2019 by Russ Peterson and Ross Anderson. The Munro Mark 1 is the first fully electric 4X4 designed and built entirely in the UK. It is a functional, reliable and affordable off-roader capable of carrying an on-board payload of 1,000KG with over 280KM of range.
Globally, over 80% of wastewater is left untreated and discharged into the environment, the equivalent of two million Olympic swimming pools of wastewater every day. WASE aims to help create a world where this waste will become a sustainable source of energy, fertiliser and water.
Anaphite was founded by Sam Burrow and Alex Hewitt who both had a passion to develop next-generation clean tech. Their vision is to accelerate the mass adoption of battery electric vehicles by developing technologies that enable faster-charging, increased-range and low-cost batteries.
Our Explore investment vertical widens our reach beyond our primary investment sectors. Explore allows us to
support and build relationships with science-led founders and companies with longer investment horizons.
REFRIGERATION-FREE VACCINE TECHNOLOGY
According to the World Health Organisation, approximately 50% of all vaccines are currently lost in transport. EnsiliTech is developing a refrigeration-free approach to transporting vaccines that will greatly improve their distribution in developing countries.
Based in Manchester, QV Bioelectronics hopes to enhance the standard of care that cancer patients receive. Their cutting-edge device, GRACE, uses advanced materials, precision oncology and surgical innovation to target diving cancer cells without affecting healthy cells.
Farms and growers need new technology to become resilient to setbacks caused by seasonal worker shortages. Muddy Machines is building field robots that do this in a sustainable way, driving agriculture to Net Zero. These robots enable growers to grow local, fresh produce more sustainably.
THE WORLD'S FIRST NEEDLE-FREE CONTINUOUS GLUCOSE MONITOR
Transdermal Diagnostics is a MedTech spin-out dedicated to developing and commercialising innovative technologies for needleless monitoring of health biomarkers in real-time. They aim to reinvent patient care and lead a paradigm-shift from treatment to prevention.
Biomaterials can fundamentally alter the performance of everyday products. The difficulty is finding methods that allow you to make these at sufficient scale. Zentraxa is solving this problem using its proprietary Zentide platform which can produce novel peptides with unique properties.
CheMastery aims to revolutionise how chemical research and manufacturing are carried out. It is estimated that about 80% of a chemist’s time is spent on low skill, repetitive manual labour, an issue CheMastery is looking to solve by making automation commonplace in chemical laboratories.
